Sarcopenia: European consensus on definition and diagnosis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics—European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as ‘presarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European Working Group for the Study of Sarcopenia (EWGSOP)156 identified sarcopenia cut-off points and tools for its measurement. They recognized the lack of diagnostic criteria for sarcopenia but integrated low muscle mass and function (strength or performance) in their terminology, believing that the relationship between these two measures is not linear nor bidirectional73,156,181.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm was meant for clinical application using gait speed (<0.8 m/s) before muscle mass or strength measurement.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, the cut-off points for the Asian populations [9] are lower than for the non-Asian individuals [7] in both genders, with young people of the same ethnic group as reference.”
From Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies (2017) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to the amount of skeletal muscle, other conditions also affect functional outcomes: muscle quality, total body fat, neurologic function, cardiovascular and pulmonary function, and other comorbid conditions.16,208”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In older people, loss of muscle strength is associated with reduced functional capacity and increased health care costs.16”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 3×
“Men: Based on quartiles of study group (n = 5,317) [27]”
BackgroundGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 1×
“The SPPB evaluates balance, gait, strength and endurance by examining an individual’s ability to stand with the feet together in side-by-side, semi-tandem and tandem positions, time to walk 8 ft and time to rise from a chair and return to the seated position five times [58].”
BackgroundEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 13×
“The re- searchers concluded that BIA was a clinically relevant measure muscle function, which would be particularly useful for patients unable or unwilling to perform grip strength tests.”
BackgroundMethodInfluentialPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“In conditions such as malignancy, rheumatoid arthritis and ageing, lean bodymass is lost while fat mass may be preserved or even increased [28].”
BackgroundJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“[67] also used standard deviations to define sarcopenia, measured in terms of skeletal muscle index (SMI), where SMI = (skeletal muscle mass/ body mass) × 100.”
BackgroundMethodGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 3×
“Intramuscular and visceral fat increase with ageing while subcutaneous fat declines [18, 32, 33].”
BackgroundGuralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898 · cited 2×
“suggested that timed usual gait provides a predictive value for the onset of disability [62].”
BackgroundMeaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“Meaningful changes in the SPPB have been defined [59, 60].”
BackgroundEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450 · cited 2×
“Sarcopenia is one of the elements of the proposed definition for cachexia [22].”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“In 1989, Irwin Rosenberg proposed the term ‘sarcopenia’ (Greek ‘sarx’ or flesh + ‘penia’ or loss) to describe this age-related decrease of muscle mass [1, 2].”
Background
Research works printed but not linked: 1
- Abellan van Kan, 2009, Gait speed as a marker of adverse outcomes, 881
Cited by
Items 901–1,000 of 1,247
Muscle quality index improves with resistance exercise training in older adults
Fragala, M. S., Fukuda, D. H., Stout, J. R., Townsend, J. R., Emerson, N. S., Boone, C. H., Beyer, K. S., Oliveira, L., & Hoffman, J. R. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.027 · Cited by 139
“The relative importance of muscle function for sarcopenic outcomes has led to more recent approaches to define sarcopenia incorporating muscle function into the diagnostic criteria (Cruz-Jentoft et al., 2010; Lauretani et al., 2003).”
BackgroundKeevil, V. L., Luben, R., Dalzell, N., Hayat, S., Sayer, A. A., Wareham, N. J., & Khaw, K.-T. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0492-6 · Cited by 149
Steves, C. J., Bird, S., Williams, F. M., & Spector, T. D. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2765 · Cited by 119
Oakland, K., Nadler, R., Cresswell, L., Jackson, D., & Coughlin, P. A. (2016) · Annals of The Royal College of Surgeons of England · doi:10.1308/rcsann.2016.0048 · Cited by 142
“This lack of definition has resulted in a lack of consensus on the optimal method to determine frailty.(9) Not all elderly patients have a frailty phenotype, which suggests that frailty is not an inevitable consequence of aging and as such, may be amenable to treatment.”
MethodFukuda, T., Bouchi, R., Terashima, M., Sasahara, Y., Asakawa, M., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., et al. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0279-y · Cited by 121
Reference values for hand grip strength in the South Korean population
Kim, C. R., Jeon, Y., Kim, M.-C., Jeong, T. H., & Koo, W. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195485 · Cited by 141
Frailty in advanced liver disease
Laube, R., Wang, H., Park, L., Heyman, J. K., Vidot, H., Majumdar, A., Strasser, S. I., McCaughan, G. W., & Liu, K. (2018) · Liver International · doi:10.1111/liv.13917 · Cited by 130
Ohara, D. G., Pegorari, M. S., dos Santos, N. L. O., Silva, C. D. F. R., Monteiro, R. L., Matos, A. P., & Jamami, M. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1079-4 · Cited by 136
Praktiknjo, M., Clees, C., Pigliacelli, A., Fischer, S., Jansen, C., Lehmann, J., Pohlmann, A., Lattanzi, B., Krabbe, V., Strassburg, C. P., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000025 · Cited by 131
New understanding of the pathogenesis and treatment of stroke-related sarcopenia
Li, W., Yue, T., & Liu, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110721 · Cited by 134
Csapo, R., Malis, V., Sinha, U., Du, J., & Sinha, S. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-209 · Cited by 125
Nabuco, H. C. G., Tomeleri, C. M., Fernandes, R. R., Sugihara Junior, P., Cavalcante, E. F., Cunha, P. M., Antunes, M., Nunes, J. P., Venturini, D., Barbosa, D. S., et al. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.04.007 · Cited by 125
Sarcopenia: Molecular Pathways and Potential Targets for Intervention
Pascual-Fernández, J., Fernández-Montero, A., Córdova-Martínez, A., Pastor, D., Martínez-Rodríguez, A., & Roche, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228844 · Cited by 125
“Furthermore, this degenerative process can exacerbate other underlying conditions, and ultimately cause a decrease in life expectancy [2,3].”
BackgroundInfluentialUltrasound‐Based Detection of Low Muscle Mass for Diagnosis of Sarcopenia in Older Adults
Minetto, M. A., Caresio, C., Menapace, T., Hajdarevic, A., Marchini, A., Molinari, F., & Maffiuletti, N. A. (2016) · PM&R · doi:10.1016/j.pmrj.2015.09.014 · Cited by 116
Rossi, A. P., Micciolo, R., Rubele, S., Fantin, F., Caliari, C., Zoico, E., Mazzali, G., Ferrari, E., Volpato, S., & Zamboni, M. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-017-0921-4 · Cited by 116
“EWGSOP definition of sarcopenia According to EWGSOP criteria, sarcopenia was defined as presence of low muscle mass, plus low muscle strength or low physical performance (1).”
InfluentialSelf-citationSarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn’s disease
Bamba, S., Sasaki, M., Takaoka, A., Takahashi, K., Imaeda, H., Nishida, A., Inatomi, O., Sugimoto, M., & Andoh, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180036 · Cited by 135
Rehabilitation Nutrition and Exercise Therapy for Sarcopenia
Kakehi, S., Wakabayashi, H., Inuma, H., Inose, T., Shioya, M., Aoyama, Y., Hara, T., Uchimura, K., Tomita, K., Okamoto, M., et al. (2022) · The World Journal of Men's Health · doi:10.5534/wjmh.200190 · Cited by 108
Sarcopenia as a comorbidity of cardiovascular disease
Sasaki, K., & Fukumoto, Y. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.10.013 · Cited by 128
Wu, I., Lin, C., Hsiung, C. A., Wang, C., Wu, C., Chan, D. D., Li, T., Lin, W., Huang, K., Chen, C., et al. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12193 · Cited by 124
Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma
Fukushima, H., Nakanishi, Y., Kataoka, M., Tobisu, K., & Koga, F. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.08.071 · Cited by 127
A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C
Kim, S.-W., Jung, H.-W., Kim, C.-H., Kim, K.-I., Chin, H. J., & Lee, H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148495 · Cited by 116
“[2–4] In detecting sarcopenia, algorithms required measuring physical performance or muscle strength and muscle mass.[5, 6] To date, many methods have been developed to measure muscle mass and diagnose sarcopenia.”
MethodHandgrip strength and physical activity in frail elderly
Lenardt, M. H., Binotto, M. A., Carneiro, N. H. K., Cechinel, C., Betiolli, S. E., & Lourenço, T. M. (2016) · Revista da Escola de Enfermagem da USP · doi:10.1590/s0080-623420160000100012 · Cited by 132
“Sarcopenia, according to European Working Group on Sarcopenia in Older People (EWGSOP), is one of the geriatric syndromes and is characterized as a progressive and generalized decrease in skeletal muscle mass at risk for adverse outcomes such as functional disability, poorer quality of life and death(6).”
Short‐term disuse promotes fatty acid infiltration into skeletal muscle
Pagano, A. F., Brioche, T., Arc‐Chagnaud, C., Demangel, R., Chopard, A., & Py, G. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12259 · Cited by 116
Mori, H., Kuroda, A., Ishizu, M., Ohishi, M., Takashi, Y., Otsuka, Y., Taniguchi, S., Tamaki, M., Kurahashi, K., Yoshida, S., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13014 · Cited by 112
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Jindal, A., & Jagdish, R. K. (2019) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2019.0015 · Cited by 141
“Sarcopenia includes loss of muscle mass and/or strength leading of physical derangements and frailty.(1,2) Presence of cirrhosis is an important risk factor for the development of sarcopenia as a result of metabolic derangements caused by hepatocyte dysfunction.”
BackgroundThe diagnostic value of the Short Physical Performance Battery for sarcopenia
Phu, S., Kirk, B., Hassan, E. B., Vogrin, S., Zanker, J., Bernardo, S., & Duque, G. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01642-4 · Cited by 133
Scott, D., Daly, R. M., Sanders, K. M., & Ebeling, P. R. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0274-z · Cited by 119
Functional impact of sarcopenia in respiratory muscles
Elliott, J. E., Greising, S. M., Mantilla, C. B., & Sieck, G. C. (2015) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2015.10.001 · Cited by 134
Tieland, M., Franssen, R., Dullemeijer, C., van Dronkelaar, C., Kim, H. K., Ispoglou, T., Zhu, K., Prince, R. L., van Loon, L. J. C., & de Groot, L. C. P. G. M. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-017-0896-1 · Cited by 123
“3 INTRODUCTION Aging is associated with the loss of muscle mass and muscle strength, also referred to as sarcopenia [1].”
Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia's ageing population?
Scott, D., Courten, B., & Ebeling, P. R. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00446 · Cited by 119
Hamaguchi, Y., Kaido, T., Okumura, S., Kobayashi, A., Shirai, H., Yao, S., Yagi, S., Kamo, N., Seo, S., Taura, K., et al. (2018) · Liver Cancer · doi:10.1159/000488779 · Cited by 128
Peball, M., Mahlknecht, P., Werkmann, M., Marini, K., Murr, F., Herzmann, H., Stockner, H., Marzi, R. D., Heim, B., Djamshidian, A., et al. (2018) · Gerontology · doi:10.1159/000492572 · Cited by 131
The Role of Ultrasound as a Diagnostic Tool for Sarcopenia
Stringer, H. J., & Wilson, D. (2018) · The Journal of Frailty & Aging · doi:10.14283/jfa.2018.24 · Cited by 112
“…two measurements can be estimated using computed tomography (CT), magnetic resonance imaging (MRI), BIA and dual-energy x-ray absorptiometry (DXA) (1–3, 16 The synopsis presented in Table 1 suggests that, on balance, ultrasound may offer the most promising option for routine diagnosis…”
InfluentialSarcopenia and osteoporosis are interrelated in geriatric inpatients
Reiss, J., Iglseder, B., Alzner, R., Mayr-Pirker, B., Pirich, C., Kässmann, H., Kreutzer, M. L., Dovjak, P., & Reiter, R. (2019) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-019-01553-z · Cited by 124
The role of sarcopenia in the risk of osteoporotic hip fracture
Oliveira, A., & Vaz, C. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-2943-9 · Cited by 132
Santos, L. P., Gonzalez, M. C., Orlandi, S. P., Bielemann, R. M., Barbosa‐Silva, T. G., Heymsfield, S. B., & COCONUT Study Group (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1605 · Cited by 122
Sarcopenia and impairment in cognitive and physical performance
Tolea, M., & Galvin, J. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s76275 · Cited by 112
Sarcopenia and Physical Function in Middle-Aged and Older Stroke Survivors
Ryan, A. S., Ivey, F. M., Serra, M. C., Hartstein, J., & Hafer-Macko, C. E. (2017) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.07.015 · Cited by 113
Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review
Campins, L., Camps, M. V., Riera, A., Pleguezuelos, E., Yébenes, J. C., & Serra‐Prat, M. (2016) · Pharmacology · doi:10.1159/000448247 · Cited by 130
Huang, D., Zhou, C.-J., Wang, S.-L., Mao, S.-T., Zhou, X.-Y., Lou, N., Zhang, Z., Yu, Z., Shen, X., & Zhuang, C. (2016) · Surgery · doi:10.1016/j.surg.2016.08.030 · Cited by 128
Masanés, F., Rojano i Luque, X., Salvà, A., Serra-Rexach, J. A., Artaza, I., Formiga, F., Cuesta, F., López Soto, A., Ruiz, D., & Cruz-Jentoft, A. J. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0844-5 · Cited by 116
Self-citationMakizako, H., Shimada, H., Doi, T., Tsutsumimoto, K., Lee, S. Y., Lee, S. C., Harada, K., Hotta, R., Nakakubo, S., Bae, S., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12197 · Cited by 130
da Rocha, I. M. G., Marcadenti, A., de Medeiros, G. O. C., Bezerra, R. A., Rêgo, J. F. M., González, M. C., & Fayh, A. P. T. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12391 · Cited by 130
“grip strength <30 and <20 kg for male and female patients, respectively).(9) CT scans were evaluated for muscle mass analysis.”
BackgroundInactivity and Skeletal Muscle Metabolism: A Vicious Cycle in Old Age
Rezuş, E., Burlui, A., Cardoneanu, A., Rezuş, C., Codreanu, C., Pârvu, M., Rusu Zota, G., & Tamba, B. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020592 · Cited by 116
“Furthermore, EWGSOP defined severe sarcopenia as the association between the three parameters [66].”
BackgroundYe, L., Liang, R., Liu, X., Li, J., Yue, J., & Zhang, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102111 · Cited by 126
Pöllänen, E., Sipilä, S., Alen, M., Ronkainen, P. H. A., Ankarberg‐Lindgren, C., Puolakka, J., Suominen, H., Hämäläinen, E., Turpeinen, U., Konttinen, Y. T., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00701.x · Cited by 121
Tanimoto, Y., Watanabe, M., Sun, W., Hirota, C., Sugiura, Y., Kono, R., Saito, M., & Kono, K. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.06.015 · Cited by 127
Strategic creatine supplementation and resistance training in healthy older adults
Candow, D. G., Vogt, E., Johannsmeyer, S., Forbes, S. C., & Farthing, J. P. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2014-0498 · Cited by 121
“(Cruz-Jentoft et al. 2010; Fielding et al. 2011), decreases the ability”
Johnson Stoklossa, C. A., Sharma, A. M., Forhan, M., Siervo, M., Padwal, R. S., & Prado, C. M. (2017) · Journal of Nutrition and Metabolism · doi:10.1155/2017/7307618 · Cited by 121
Hamer, M., Batty, G. D., & Kivimaki, M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.124 · Cited by 121
Yamada, M., Moriguch, Y., Mitani, T., Aoyama, T., & Arai, H. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12209 · Cited by 117
Cesari, M., Landi, F., Calvani, R., Cherubini, A., Bari, M. D., KORTEBEIN, P. M., Signore, S. D., Lain, R. L., Vellas, B. J., Pahor, M., et al. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0716-1 · Cited by 126
Self-citationOlesen, S. S., Büyükuslu, A., Køhler, M., Rasmussen, H. H., & Drewes, A. M. (2019) · Pancreatology · doi:10.1016/j.pan.2019.01.006 · Cited by 127
Sarcopenia and swallowing disorders in older people
Azzolino, D., Damanti, S., Bertagnoli, L., Lucchi, T. A., & Cesari, M. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01128-3 · Cited by 136
“Just recently, the European Working Group on Sarcopenia in Older People (EWGSOP) released an update of the defining criteria for sarcopenia previously published in 2011 [8].”
BackgroundInfluentialWeerink, L. B. M., van der Hoorn, A., van Leeuwen, B. L., & de Bock, G. H. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12529 · Cited by 129
Yang, Y. J., & Kim, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052604 · Cited by 112
Chung, S. M., Moon, J. S., & Chang, M. C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.681232 · Cited by 167
“were considered as the standard criteria for the diagnosis of sarcopenia (6, 7).”
Backgroundda Silva Alexandre, T., De Oliveira Duarte, Y. A., Ferreira Santos, J. L., Wong, R., & Lebrão, M. L. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0465-9 · Cited by 120
“To improve the identification and treatment of the syndrome and reduce associated adverse outcomes, the European Working Group on Sarcopenia in Older People (EWGSOP) recommends a diagnosis of sarcopenia using the presence of low muscle mass (LMM) plus low muscle strength (LMS) or low physical performance (LPP) in clin…”
InfluentialVoulgaridou, G., Tyrovolas, S., Detopoulou, P., Tsoumana, D., Drakaki, M., Apostolou, T. S., Chatziprodromidou, I. P., Papandreou, D., Giaginis, C., & Papadopoulou, S. Κ. (2024) · Nutrients · doi:10.3390/nu16030436 · Cited by 131
Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial
Martínez-Arnau, F. M., Fonfría-Vivas, R., Buigues, C., Castillo, Y., Molina, P., Hoogland, A. J., van Doesburg, F., Pruimboom, L., Fernández-Garrido, J., & Cauli, O. (2020) · Nutrients · doi:10.3390/nu12040932 · Cited by 120
“Sarcopenia was measured according to the guidelines of the European Working Group on Sarcopenia in Older People (EWGSOP) [1], and can be assessed by means of indirect measures of muscle function and muscle mass, such as low walking speed (≤0.”
MethodInfluentialDrummond, M. J., Fry, C. S., Glynn, E. L., Timmerman, K. L., Dickinson, J. M., Walker, D. K., Gundermann, D. M., Volpi, E., & Rasmussen, B. B. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01408.2010 · Cited by 120
Perkisas, S., & Vandewoude, M. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2743 · Cited by 120
Self-citationGonzález-Montalvo, J. I., Alarcón, T., Gotor, P., Queipó, R., Velasco, R., Hoyos, R., Pardo, A., & Otero, Á. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12590 · Cited by 132
Nutrition Screening vs Nutrition Assessment: What’s the Difference?
Correia, M. I. T. D. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617719669 · Cited by 137
Nutritional challenges for older adults in Europe: current status and future directions
Kehoe, L., Walton, J., & Flynn, A. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002744 · Cited by 132
“Studies in recent years have highlighted a possible need for increased protein requirements in older adults to prevent the loss of lean body mass, particularly muscle mass (sarcopenia)((24)) in order to support optimal health and maintain functionality.”
BackgroundSobestiansky, S., Michaëlsson, K., & Cederholm, T. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1338-1 · Cited by 126
Self-citationHirai, K., Tanaka, A., Homma, T., Goto, Y., Akimoto, K., Uno, T., Uchida, Y., Miyata, Y., Inoue, H., Ohta, S., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.08.010 · Cited by 124
Sex Differences in Inflammation and Muscle Wasting in Aging and Disease
Peruta, C. D., Lozanoska‐Ochser, B., Renzini, A., Moresi, V., Riera, C. S., Bouché, M., & Coletti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054651 · Cited by 128
Adverse outcomes of frailty in the elderly: the Rotterdam Study
Lahousse, L., Maes, B., Ziere, G. J., Loth, D. W., Verlinden, V. J. A., Zillikens, M. C., Uitterlinden, A. G., Rivadeneira, F., Tiemeier, H. W., Franco, O. H., et al. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9924-1 · Cited by 126
Lee, J., Hong, Y.-P., Shin, H. J., & Lee, W. (2015) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.15.055 · Cited by 119
Lee, D.-K., Kang, M., Lee, T.-S., & Oh, J. (2015) · Brazilian Journal of Physical Therapy · doi:10.1590/bjpt-rbf.2014.0096 · Cited by 140
Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men
Pereira, F. B., Leite, A. F., & Paula, A. P. D. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000011 · Cited by 116
KEMMLER, W. K., Bebenek, M., Engelke, K., & von Stengel, S. (2013) · AGE · doi:10.1007/s11357-013-9575-2 · Cited by 133
The assessment and impact of sarcopenia in lung cancer: a systematic literature review
Collins, J., Noble, S., Chester, J., Coles, B., & Byrne, A. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003697 · Cited by 119
“The term sarcopenia is derived from the Greek meaning ‘poverty of flesh’ and is characterised by a triad of progressive loss of skeletal muscle mass, muscle strength and physical performance.(6) It was originally described in the elderly non-cancer population, and is often now defined as a geriatric syndrome associate…”
Monaco, M. D., Castiglioni, C., Vallero, F., Monaco, R. D., & Tappero, R. (2012) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.05.002 · Cited by 125
Okumura, S., Kaido, T., Hamaguchi, Y., Kobayashi, A., Shirai, H., Fujimoto, Y., Iida, T., Yagi, S., Taura, K., Hatano, E., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5668-3 · Cited by 126
Nutritional Aspects of Dysphagia Management
Gallegos, C., la Fuente, E. B., Clavé, P., Costa, A., & Assegehegn, G. (2016) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2016.11.008 · Cited by 143
Vitamin B12 deficiency might be related to sarcopenia in older adults
Bulut, E. A., Soysal, P., Aydın, A. E., Dokuzlar, Ö., Koçyiğit, S. E., & Işık, A. T. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.05.017 · Cited by 126
Reijnierse, E. M., de van der Schueren, M. A. E., Trappenburg, M. C., Doves, M., Meskers, C. G. M., & Maier, A. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185837 · Cited by 128
Kim, M., & Won, C. W. (2019) · Age and Ageing · doi:10.1093/ageing/afz091 · Cited by 130
Immune system and sarcopenia: Presented relationship and future perspective
Zhang, X., Li, H., He, M., Wang, J., Wu, Y., & Li, Y. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111823 · Cited by 123
Iinuma, T., Arai, Y., Fukumoto, M., Takayama, M., Abe, Y., Asakura, K., Nishiwaki, Y., Takebayashi, T., Iwase, T., Komiyama, K., et al. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03780.x · Cited by 124
Schlender, J., Meyer, M. C., Thelen, K., Krauß, M., Willmann, S., Eißing, T., & Jaehde, U. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0422-3 · Cited by 129
Landi, F., Calvani, R., Ortolani, E., Salini, S., Martone, A. M., Santoro, L., Santoliquido, A., Sisto, A., Picca, A., & Marzetti, E. (2017) · Osteoporosis International · doi:10.1007/s00198-017-3929-z · Cited by 126
Self-citationCai, C., Song, X., Chen, Y., Chen, X., & Yu, C. (2020) · Hepatology International · doi:10.1007/s12072-019-09964-1 · Cited by 118
The Health Impact of Nighttime Eating: Old and New Perspectives
Kinsey, A., & Ormsbee, M. (2015) · Nutrients · doi:10.3390/nu7042648 · Cited by 118
Bergamin, M., Ermolao, Tolomio, S., Berton, Sergi, & Zaccaria (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s44198 · Cited by 118
Sarcopenic obesity as an independent risk factor of hypertension
Park, S. H., Park, J. H., Song, P. S., Kim, D. K., Kim, K. H., Seol, S. H., Kim, H. K., Jang, H. J., Lee, J. G., Park, H. Y., et al. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.002 · Cited by 118
Willadt, S., Nash, M., & Slater, C. R. (2016) · Scientific Reports · doi:10.1038/srep24849 · Cited by 115
Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems
Komatsu, R., Okazaki, T., Ebihara, S., Kobayashi, M., Tsukita, Y., Nihei, M., Sugiura, H., Niu, K., Ebihara, T., & Ichinose, M. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12297 · Cited by 116
“The original definition of sarcopenia is the loss of skeletal muscle mass and strength that occurs with advancing age.(21) Recently, the cause of primary sarcopenia was suggested to be ageing itself, and the cause of secondary resulted from triggers such as organ failure or inflammatory diseases.”
BackgroundPrevalence of Sarcopenia in Geriatric Hospitalized Patients
Smoliner, C., Sieber, C. C., & Wirth, R. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.027 · Cited by 117
Bennett, B. T., Mohamed, J. S., & Alway, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083518 · Cited by 116
Aggio, D. A., Sartini, C., Papacosta, O., Lennon, L. T., Ash, S., Whincup, P. H., Wannamethee, S. G., & Jefferis, B. J. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.040 · Cited by 110
Bradlee, M. L., Mustafa, J., Singer, M. R., & Moore, L. L. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx070 · Cited by 116
Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed?
Ilich, J. Z., Kelly, O. J., & Inglis, J. E. (2016) · Current Gerontology and Geriatrics Research · doi:10.1155/2016/7325973 · Cited by 115
Beaudart, C., Bruyère, O., Geerinck, A., Hajaoui, M., Scafoglieri, A., Perkisas, S., Bautmans, I., Gielen, E., Reginster, J.-Y., & Buckinx, F. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.09.012 · Cited by 113
Sarcopenia and sarcopenic obesity
Choi, K. M. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.2.86 · Cited by 113
Association between Mediterranean diet and hand grip strength in older adult women
Barrea, L., Muscogiuri, G., Di Somma, C., Tramontano, G., De Luca, V., Illario, M., Colao, A., & Savastano, S. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.03.012 · Cited by 114
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J. A., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H. A., Boers, M., Brandi, M. L., Bruyère, O., et al. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0517-y · Cited by 112
“In the words of the European Working Group on Sarcopenia in Older People (EWGSOP), sarcopenia is a condition ‘characterized by progressive and generalized loss of skeletal muscle mass and strength, with a risk of adverse outcomes such as physical disability, poor quality of life and death’ [2].”
BackgroundInfluentialSelf-citationRom, O., Kaisari, S., Aizenbud, D., & Reznick, A. Z. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06532.x · Cited by 112
Metadata
- Authors
- Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., & Zamboni, M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Damiaan Dicht bij het leven (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Clermont Université 4 , UFR Médecine, UMR 1019, F-63001 Clermont-Ferrand , France
- Uppsala University (SE)
- Università Cattolica del Sacro Cuore (IT)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital of Geneva (CH)
- Hôpital de La Grave (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Charles University (CZ)
- University of Antwerp (BE)
- University of Verona (IT)
- Corresponding author
- Cruz-Jentoft, Alfonso J.
- ORCID
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-13
- Volume
- 39
- Issue
- 4
- Pages
- 412-423
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC2886201
- OpenAlex
- W2102902846
- Cited by
- 11,601
- References
- 80
- Citations by year
- 2026: 468 · 2025: 791 · 2024: 879 · 2023: 913 · 2022: 1031 · 2021: 1056 · 2020: 1131 · 2019: 1021 · 2018: 1059 · 2017: 811 · 2016: 685 · 2015: 591 · 2014: 494 · 2013: 290 · 2012: 207
- FWCI
- 142.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- European Geriatric Medicine Society
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenia, older adults, diagnostic criteria, muscle mass, muscle strength, physical performance, walking speed, grip strength, sarcopenic obesity, frailty, cachexia, pre-sarcopenia, cut-off values, case-finding algorithms, comprehensive geriatric assessment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cachexia, Female, Humans, Male, Obesity, Geriatric Assessment, Frail Elderly, Muscle, Skeletal, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

